Skip to content
Brand AI

Yangtze River Pharmaceutical

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    China's market regulator fines Yangtze River Pharmaceutical Group

    China's State Administration for Market Regulation fined Yangtze River Pharmaceutical Group 764 million yuan and ordered it to stop the conduct. The regulator found that the group had reached agreements with downstream businesses to fix or set minimum resale prices for medicines, excluding and restricting competition and harming consumers' legitimate rights and interests and the public interest.

    Source